Active Ingredient: OXALIPLATIN
Proprietary Name: OXALIPLATIN
Dosage Form; Route of Administration: INJECTABLE; INTRAVENOUS
Strength: 100MG/20ML (5MG/ML)
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: A208523
Product Number: 002
Approval Date: Feb 10, 2017
Applicant Holder Full Name: CHARTWELL MOLECULAR HOLDINGS LLC
Marketing Status:
Discontinued
Patent and Exclusivity Information